Anti-Escherichia coli asparaginase antibody levels determine the activity of second-line treatment with pegylated E coli asparaginase: a retrospective analysis within the ALL-BFM trials (Q84975509)

From Wikidata
Jump to navigation Jump to search
scientific article published on 22 September 2011
edit
Language Label Description Also known as
English
Anti-Escherichia coli asparaginase antibody levels determine the activity of second-line treatment with pegylated E coli asparaginase: a retrospective analysis within the ALL-BFM trials
scientific article published on 22 September 2011

    Statements

    title
    Anti-Escherichia coli asparaginase antibody levels determine the activity of second-line treatment with pegylated E coli asparaginase: a retrospective analysis within the ALL-BFM trials (English)
    1 reference
    stated in
    Europe PubMed Central
    PubMed ID
    21940824
    reference URL
    https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21940824%20AND%20SRC:MED&resulttype=core&format=json
    retrieved
    13 February 2020
    author name string

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit
                      Retrieved from "https://www.wikidata.org/w/index.php?title=Q84975509&oldid=1792298285"